Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST

Summary

The main objective of this study is to investigate the tolerability of enecadin in patients with acute ischemic stroke. Furthermore, the pharmacokinetics of enecadin in both male and female patients with acute ischemic stroke will be assessed. Efficacy trends will be evaluated up to day 30 post stroke.

Timeline

Start

2006-05

Primary completion

2009-05

Completion

2009-05

Outcome

Outcome not reported

Stopped: “Scientific data called into question the viability of the substance class”

Drugs

Indications